High-potency drugs – challenges and factors
Posted: 23 October 2020 | Eurofins Amatsigroup | No comments yet
High-potency drugs present numerous opportunities for improved drug selectivity, efficacy and safety profiles.
They represent a growing area of global development focus for oncology and hormone-based indications with applications from niche, small volume products to larger commercial scales.
Although this class of molecule offers numerous benefits to patients, they require particular care and attention when ensuring the safety of those involved in their manufacture and handling, in addition to their inherent complexity.
Drug Development, Drug Manufacturing, Drug Safety, Good Manufacturing Practice (GMP)